Luseogliflozin Ehime Diabetes Study (LED study)
Latest Information Update: 22 Apr 2022
Price :
$35 *
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LED
- 15 Apr 2022 Results published in the Diabetes Therapy
- 09 Feb 2019 Status changed from recruiting to completed.
- 19 Aug 2016 New trial record